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Objective: In obesity, the excessive adipose tissue increases the synthesis of inﬂammatory
cytokines, which appear to alter the metabolism of minerals, such as zinc. However, the
mechanisms involved remain unclear. This study investigated whether the concentrations
of  interleukin-6 (IL-6) and tumor necrosis factor- (TNF-) in plasma can to inﬂuence bio-
chemical parameters of zinc in obese women.
Methods: Seventy-six pre-menopausal women, aged between 20 and 50 years, were divided
into two groups: the case group, composed of obese women (n = 37) and the control group,
composed of non-obese women (n = 39). Analysis of the plasmatic and erythrocytary zinc,
and  plasmatic cytokines were conducted by ﬂame atomic absorption spectrophotometry
and by ELISA, respectively.
Results: The plasmatic zinc and concentrations of IL-6 in plasma did not show signiﬁ-
cant differences between obese women and controls (p > 0.05). The erythrocytary zinc was
36.4  ± 15.0 g/gHb in the case group, and 45.4 ± 14.3 g/gHb (p = 0.025) in the control group.
The  concentrations of TNF- in plasma were 42.0 ± 11.9 pg/mL and 19.0 ± 1.0 pg/mL in obese
women and in controls, respectively (p < 0.001). The plasmatic zinc had a signiﬁcant negative
correlation with the values of TNF (r = −0.44, p = 0.015).
Conclusion: Obese women presented lower concentrations of erythrocytary zinc than the
control group. The study demonstrated a probable inﬂuence of the inﬂammatory process
on  metabolism of zinc in obese patients.
Concentrac¸ões plasmáticas  de  IL-6  e  TNF-  e  sua  relac¸ão com  a  zincemia
em  mulheres  obesas
r  e  s  u  m  o
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Objetivo: Na obesidade, o excesso de tecido adiposo aumenta a síntese de citocinas inﬂa-
matórias que parecem alterar o metabolismo de minerais, como o zinco. Entretanto, os
mecanismos envolvidos neste processo ainda não estão totalmente esclarecidos. O estudo
 Study conducted at the Department of Nutrition, Universidade Federal do Piauí, Teresina, PI, Brazil.
∗ Corresponding author.
E-mail: dilina.marreiro@gmail.com (D.N. Marreiro).
104-4230  © 2013 Elsevier Editora Ltda. 
ttp://dx.doi.org/10.1016/j.ramb.2013.03.003
Este é um artigo Open Access sob a licença de CC BY-NC-ND
430  r e v a s s o c m e d b r a s . 2 0 1 3;5  9(5):429–434
Inﬂamac¸ão
Interleucina-6
Fator de necrose tumoral-
investigou se as concentrac¸ões de interleucina-6 (IL-6) e fator de necrose tumoral- (TNF-)
no plasma podem inﬂuenciar os parâmetros bioquímicos do zinco.
Métodos: Setenta e três mulheres, com idade entre 20 e 50 anos, foram distribuídas em
dois  grupos: grupo caso, composto de obesas (n = 37) e grupo controle, composto de não
obesas (n = 39). Análises de zinco plasmático e eritrocitário e as citocinas inﬂamatórias plas-
máticas foram realizadas pelo método da espectrofotometria de absorc¸ão atômica e pelo
ELISA, respectivamente.
Resultados: O zinco plasmático e as concentrac¸ões de IL-6 no plasma não mostraram
diferenc¸as  signiﬁcativas entre as mulheres obesas e grupo controle (p > 0,05). O valor do
zinco eritrocitário foi 36,4 ± 15,0 g/gHb nas mulheres obesas e 45,4 ± 14,3 g/gHb (p = 0,025)
no  grupo controle. As concentrac¸ões de TNF- no plasma foram 42,0 ± 11,9 pg/mL e
19,0 ± 1,0 pg/mL nas mulheres obesas e controles, respectivamente (p < 0,001). O zinco plas-
mático apresentou uma correlac¸ão negativa signiﬁcativa com os valores de TNF- (r = −0,44,
p  = 0,015).
Conclusão: As mulheres obesas apresentaram menores concentrac¸ões de zinco eritrocitário
em  relac¸ão ao grupo controle. O estudo mostra uma provável inﬂuência do processo inﬂa-
matório no metabolismo do zinco em pacientes obesos.
13 EIntroduction
Obesity is directly related to changes in the endocrine and
metabolic functions of adipose tissue. In obese individuals,
this tissue increases the capacity for synthesis of adipocy-
tokines or adipokines with proinﬂammatory action. Studies
have identiﬁed that metabolic disturbances in obesity are
related to macronutrient levels. Recently, there has been an
increased interest on the contribution of minerals in various
pathophysiological changes associated with obesity.1–3
Zinc is one of the most important minerals for metabolism.
Among its biological functions, this element is a cofactor of
over 300 metalloenzymes; it acts in the catalytic activity of
several enzymes, such as carbonic anhydrase, alcohol dehy-
drogenase, alkaline phosphatase, and enzymes involved in the
metabolism of carbohydrates, lipids, and proteins.4,5
Tissues of obese animals have low concentrations of
micronutrients, such as zinc, copper, iron, and manganese.
Kennedy and Failla6 observed low concentrations of zinc in
the skin, muscle, pancreas, and bone of obese mice. Moreover,
the liver, intestine, and adipose tissues had higher zinc con-
centrations, suggesting a possible change in the distribution
of the mineral in the obese.
A relationship between zinc status and cytokine pro-
duction is reported in disorders associated with chronic
inﬂammation, such as obesity. This process may occur
through an increase in the content of hepatic zinc at the
expense of plasmatic zinc. Elevated concentrations of gluco-
corticoids lead to a reduction of plasmatic zinc and an increase
in zinc uptake by the liver. These data show the involvement of
synergistic participation of interleukin-6 (IL-6), tumor necrosis
factor- (TNF-),  and glucocorticoids on the metabolic behav-
ior of zinc; the combination of these elements depend on an
adequate zinc content in the liver.7,8
In humans, inﬂammatory cytokines have been demon-
© 20strated to both up- and down-regulate the expression of
speciﬁc cellular zinc transporters (ZnT’s and Zip’s), in response
to an increasing demand for zinc in inﬂammation.9,10 In these
processes, there is an increase of expression of encodinggenes for zinc-transporter protein Zip-14, which promotes the
uptake of zinc from the extracellular compartment to
the interior of the cells. In obesity, a high concentration of IL-6
in plasma promotes an increase in gene expression of this
transporter, which may alter the distribution of zinc in cel-
lular compartments.7,11 Studies have demonstrated a rapid
decrease in zinc plasma concentration that was preceded by
prominent increases in concentration of TNF- and IL-6 in
plasma in humans exposed to inﬂammation.9,12,13
Considering the importance of obesity as a chronic disease,
the secretion of adipocytokines and other proteins in the adi-
pose tissue, and the possible inﬂuence of these metabolites
on the homeostasis of zinc, this study aimed to investigate
the relationship between biochemical parameters of zinc and
the concentrations of IL-6 and of TNF- in the plasma of obese
women.
Methods
This was a clinical and case-control study, involving 76 ran-
domly selected adult females, aged between 20 and 50 years,
who sought treatment at an endocrinology clinic. This sam-
ple derived from the study by Ferro et al.14 The analysis of
concentrations of proinﬂammatory cytokines in plasma was
performed from a biobank of samples arising from the afore-
mentioned research,14 developed in the Universidade Federal
do Piauí (UFPI) by researchers involved in this study.
The obese women (n = 37) who presented at the clinic were
selected for the study if they met  the following criteria: their
body mass index (BMI) was higher than 30 kg/m2; they were
not taking any vitamin-mineral supplementation and/or other
medicines; they did not have any illnesses that could inter-
fere with zinc-related nutritional status and metabolic proﬁle,
such as diabetes mellitus, chronic renal insufﬁciency, chronic
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDdiarrhea, and malabsorption syndrome; and were nonsmok-
ers. The control group (n = 39) was selected according to the
same criteria as the obese women, but had a BMI  between
18.5 kg/m2 and 24.9 kg/m2. The study was approved by the
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sensitivity.23 Thus, unlike the results obtained in plasma,
the mean values of erythrocytary zinc in the obese women
were signiﬁcantly lower than in the controls. The data are
Table 1 – Subjects characteristics.
Parameters Obese women Mean ± SD Control Mean ± SD p
Age (years) 33.7 ± 7.89 31.2 ± 7.82 0.79
Weight (kg) 82.6* ± 11.40 54.4* ± 5.4 0.01
Height (cm) 154.3 ± 0.05 157.6 ± 0.06 0.52
BMI (kg/m2) 34.5* ± 3.40 21.7* ± 1.90 0.001
WC (cm) 102.4* ± 8.50 75.4* ± 6.30 0.04
BMI, body mass index; WC, waist circumference.
∗ Values statistically signiﬁcant between the obese women and the
control group, Student’s t- test (p < 0.05).
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thics Committee of the UFPI, and the individuals signed an
nformed consent.
ssessment  of  nutritional  status
MI  was calculated using measures of weight in kilograms and
eight in meters. The classiﬁcation of obesity according to BMI
as conducted in agreement with the criteria of the World
ealth Organization.15
ollection  of  biological  material  and  biochemical
arameters
lood samples (25 mL)  were taken in the morning, from
:30 am to 9:00 am,  after at least a 12-hour fast. The plasma
as separated from the total blood by centrifugation at
,831 xg for 15 minutes at 4 ◦C (SIGMA 2K15 centrifuge). Three
liquots of each plasma sample were diluted at a ratio of 1:4
ith Milli-Q® water and aspirated directly into the ﬂame of the
tomic absorption spectrophotometer.16 Tryptizol® (Merck),
repared by dilution with Milli-Q® water with 3% glycerol
t 0.1, 0.2, 0.3, 0.5, and 1.0 g/mL dilutions were used as a
tandard.
For the separation of the erythrocytes, the erythrocytary
ass obtained from total blood was washed three times with
 mL  of 0.9% saline solution, homogenized by inversion, and
entrifuged at 2,493 xg for 10 minutes (Sorvall® RC-SB) at 4 ◦C.
fter the last centrifugation, the saline solution was aspirated,
nd the erythrocytary mass was carefully extracted using
 micropipette, placed in demineralized Eppendorf tubes,
nd stored at −20 ◦C for zinc and hemoglobin analysis.17 To
xpress the results in terms of mass zinc/mass of hemoglobin
g/gHb), the erythrocytary lysis was measured according to
he cyanmethemoglobin method.18
The erythrocyte analysis was performed using atomic
bsorption spectrophotometry.12 Tryptizol® was used as a
eference, prepared by dilution in Milli-Q® water at concentra-
ions of 0.1, 0.2, 0.3, 0.5, and 1.0 g/mL. The reference interval
or plasmatic and erythrocytary zinc is 70-110 g/dL and 40-
4 g/gHb, respectively.19,20
The concentrations of IL-6 and of TNF- in plasma were
erformed by enzyme linked immunosorbent assay (ELISA),
sing the Lincoplex Cytokine Analytes Kit (Linco Research -
issouri, USA), according to the methodology recommended
y the manufacturer. The limits of detection for IL-6 and TNF-
ere 0.3 to 0.7 pg/mL and 0.1 pg/mL, respectively.
tatistical  analysis
ata were processed and analyzed using the S-PLUS software
or Windows, version 3.2, and Minitab Release, version 11.0 for
indows 9.0. Student’s t-test and Mann-Whitney tests were
sed to determine whether differences on the main study vari-
bles existed between groups. Pearson’s correlation analysis
as  applied to establish the correlation of concentrations of
L-6 and TNF- in plasma with the plasmatic and erythrocy-
ary zinc. Signiﬁcance was established at p < 0.05 a priori for all
tatistical tests.1 3;5  9(5):429–434 431
Results
The subject’s characteristics are shown in Table 1. In this study,
a signiﬁcant difference between the case and control groups
was observed regarding erythrocytary zinc and the plasmatic
TNF-, as demonstrated in Table 2, and a signiﬁcant nega-
tive correlation between plasmatic zinc and TNF- in obese
patients (r = −0.44, p = 0.015), shown in Table 3 and Fig. 1.
Discussion
There was no statistically signiﬁcant difference between both
groups (p > 0.05) regarding mean concentrations of zinc in
plasma. It is worth noting that the plasma is a parameter of
zinc that has a fast dynamic, constantly under homeostatic
control, which may change in response to certain condi-
tions, such as stress, infection, hormonal action, and food
intake.21,22 These factors may have inﬂuenced the results of
plasmatic zinc found in this study.
Another important aspect is that, in the bloodstream, 80%
of zinc is present in the erythrocytes and only 16% is found
in plasma. Since the half-life of erythrocytes is 120 days,
erythrocytary zinc appears to be a parameter that assesses
the nutritional status of this trace element with higher0 10 20 30 40 50
TNF-(pg /ml)
Fig. 1 – Correlation analysis between plasmatic zinc and
concentration of TNF- in plasma in obese women. n = 37,
r = −0.44, p = 0.015.
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Table 2 – Plasma and erythrocytary zinc, and plasma concentrations of IL-6 and of TNF-. Values are means standard
deviation.
Parameters Obese women Mean ± SD Control Mean ± SD p
Plasma zinc (g/dL) 72.2 ± 9.0 73.4 ± 8.5 0.48
Erythrocytary zinc (g/gHb) 36.4a ± 15.0 45.4* ± 14.3 0.025
IL-6 (pg/mL) 76.38 ± 45.00 73.65 ± 27.10 0.76
TNF- (pg/mL) 42.02b ± 11.91 18.98b ± 0.97 0.001
IL-6, interleukin 6; TNF-,  tumor necrosis factor-.
a Values signiﬁcantly different between the obese women and the control group, student T test (p < 0.05).
b Values statistically signiﬁcant between the obese women and the control group, Mann-Whitney test (p < 0.05).
Table 3 – Correlation analysis results for concentration of proinﬂammatory cytokines IL-6 and TNF- in plasma and
biochemical parameters of zinc in obese women.
Parameters Plasma Zn Erythrocytary Zn
Correlation coefﬁcient (r) p Correlation coefﬁcient (r) p
IL-6 (pg/mL) −0.30 0.082 0.11 0.526
TNF- (pg/mL) −0.44a 0.015 −0.17 0.372
ctor-
ontror, correlation coefﬁcient; IL-6, interleukin 6; TNF-,  tumor necrosis fa
a Values statistically signiﬁcant between the obese women and the c
consistent with those found by Marreiro, Fisberg, Cozzolino24
and by Ozata et al.25
The compartmentalization and metabolism of zinc in
obesity have been extensively investigated. In the study by
Begin-Heick et al.,26 elevated zinc concentrations were found
in the adipose tissue, liver, and muscle of obese mice. Accord-
ing to the authors, high concentrations of hormones, such as
glucocorticoids, stimulate the synthesis of metallothionein, a
protein that acts in the transportation and retention of zinc in
some tissues.
Some mechanisms responsible for the compartmental-
ization of zinc in obese individuals are reported, such as
the inﬂuence of zinc-transporter proteins and of the inﬂam-
matory process. Schmidt et al.27 assessed the expression of
zinc-transporter proteins, from the Zips and ZnTs families, in
visceral and subcutaneous adipose tissue of obese patients,
and it was observed that most of these proteins are expressed
at a higher level in subcutaneous adipose tissue. According
to the authors, the high gene expression of zinc-transporter
proteins suggests that obesity can inﬂuence the system that
transports this mineral in adipose tissue, favoring the mani-
festation of hypozincemia in obese individuals. However, the
possible mechanisms involved are still unclear.
Some studies indicate the involvement of pro-
inﬂammatory cytokines secreted by adipocytes in alterations
often found in the metabolic behavior of zinc in obese
patients. It is currently understood that adipose tissue, in
addition to its function of storing energy reserves in the
form of triglycerides, is an endocrine organ capable of pro-
ducing several hormones and signaling molecules known as
adipocytokines or adipokines. IL-6, IL-8, and TNF-, secreted
by adipose tissue, are molecules that have pro-inﬂammatory
function, and are found in high concentrations in obese
subjects.1,28
The mean concentrations of pro-inﬂammatory adipokine
IL-6 in plasma did not have a statistically signiﬁcant difference; Zn, zinc.
l group, student T test (p < 0.05).
between groups. However, Piva et al.29 found elevated concen-
trations of IL-6 in obese patients. The discrepancy observed in
these results can be attributed to the sensitivity in the protocol
used to analyze these cytokines.
Unlike the results of IL-6, the plasma concentrations of
TNF- in the obese women were higher than in the con-
trol group. These results are similar to those found by Park
et al.30 and by Winkler et al.31 in obese patients. The impact of
the secretion of proinﬂammatory adipokines in adipocytes on
metabolic disorders associated with obesity (such as insulin
resistance, heart diseases, and liver diseases) has been widely
demonstrated.
To better understand zinc metabolism in obese patients,
the inﬂuence of inﬂammatory markers on the concentration
of zinc in plasma was investigated. Although the plasmatic
zinc was not different between the groups, there was a signiﬁ-
cant negative correlation between the concentrations of TNF-
in plasma and plasmatic zinc (r = −0.44, p = 0.015). Accord-
ing to Cousins et al.,7 TNF- is a proinﬂammatory cytokine
capable of stimulating the expression of encoding genes for
zinc-transporter protein, such as Zip-14 and Zip-6, which con-
tribute to the inﬂux of zinc to the cells and speciﬁc tissues,
causing a reduction of this mineral in blood components.
Other studies that investigated the existence of a neg-
ative association between pro-inﬂammatory markers and
biochemical parameters of zinc suggest that this mineral is an
important tool in the control of the expression of inﬂamma-
tory cytokines. Zinc supplementation stimulates the synthesis
of A-20 protein, which, in turn, contributes to reducing the
activation of the signaling pathway of nuclear factor kappa
, preventing the synthesis and secretion of TNF- and other
pro-inﬂammatory cytokines.32,33
Considering the complexity of the mechanisms involved
in the changes of the behavior of mineral metabolism in
obese patients, and the likely inﬂuence of pro-inﬂammatory
adipokines in these alterations, further studies on the role of
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hese molecules in the distribution of zinc in obese individuals
ay contribute to a better understanding of the issue.
It is important to highlight the speciﬁcity and sensitivity
f the kits used to analyze the inﬂammatory cytokines IL-6
nd TNF-, which certainly compromised the consistency of
he data in this study. This discussion is also based on the
bsence of a homeostatic control of these substances, because
he synthesis of cytokines is inﬂuenced by several factors, such
s acute or chronic subclinical inﬂammation, which probably
nﬂuenced the results found in this study.
onclusion
he obese women evaluated in this study presented lower ery-
hrocytary zinc levels than the control group. Furthermore,
he analysis of the correlation between pro-inﬂammatory
ytokines and biochemical parameters of zinc only achieved
tatistical signiﬁcance in relation to TNF- - this molecule has
 negative correlation with plasmatic zinc. This result sug-
ests a probable inﬂuence of the inﬂammatory process on the
etabolism of zinc in obese patients. However, the inconsis-
ent results of studies on the subject reinforce the need for
urther studies that may elucidate the mechanisms involved
n metabolic aspects of zinc in obesity.
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